2025 Results
The SOL Group is committed to balanced and sustainable economic and financial growth, creating lasting value over the long term.
The SOL Group
An International Group with Strong Italian Roots
Founded in Italy in 1927, the SOL Group operates in the production, applied research and marketing of technical and medical gases, home healthcare, biotechnology and renewable energy generation.
Today, the Group operates in 33 countries with 7,623 employees, serving more than 50,000 industrial clients, 700 major healthcare clients and over 870,000 patients. In 2025, the Group generated revenue of €1,776.1 million.
The parent company, SOL S.p.A., has been listed on the Italian Stock Exchange since July 1998.
60,4%
of investments directed to the technical gases sector
39,6%
of investments directed to the home healthcare sector
Clients and Patients
Putting our clients and patients at the centre of what we do, and ensuring their satisfaction, are key priorities. We are constantly developing services and solutions designed to meet their needs across the industrial, medical and healthcare sectors.
50,000
Industrial Clients
870,000
Patients Receiving Care
ENVIRONMENT
The SOL Group regards the environment as a shared asset that must be protected for the benefit of all. We continually invest in improving our production processes and organisational practices, with the aim of reducing the environmental impact of our activities.
38.164
Tonnes of CO₂ equivalent avoided through renewable energy generation
68.672
Tonnes of CO₂ equivalent recovered from other processes
PEOPLE
Our people are a strategic asset and fundamental to the Group’s success. We are committed to supporting their well-being and development, fostering professional growth, engagement and a strong connection with the company.
7.623
Our Employees
94%
Employees on Permanent Contracts